dostarlimab
gsk
['paradigm', 'dostarlimab', 'rectal']
paradigm shattering studies do not come every so often. dostarlimab for dmmr rectal cancer is certainly one of them with 100% cr rate. incredible results in what may induct a better future for our patients! #asco22 
Hematology-Oncology fellow @MountSinaiNYC????????? 
Interests: #lymsm, #mmsm, Cellular therapies
@nytimes https://t.co/ooNmeRfxJf